
New Treatments Show Promise for Two of the Most Deadly Types of Cancer
This is then steered through the brain to the tumor while avoiding healthy tissue and emitting heat inside the tumor that kills the surrounding tumor cells....The new research found that how much of the tumor is destroyed by the laser is a factor in how long a patient survives. Patients with 91 percent or more of the tumor cleared survived 2.1 years from diagnosis—while surgery to remove the tumor gives a survival rate of about 1.5 years. It maintains a patient's quality of life and requires only a short hospital stay.Leuthardt said, "When patients are told they have months to live, having the option of a low-risk procedure that gets them back home to their families in just over a day is profoundly meaningful."Dr.
- ▪This is then steered through the brain to the tumor while avoiding healthy tissue and emitting heat inside the tumor that kills the surrounding tumor cells....The new research found that how much of the tumor is destroyed by the laser is a
- ▪Patients with 91 percent or more of the tumor cleared survived 2.1 years from diagnosis—while surgery to remove the tumor gives a survival rate of about 1.5 years.
- ▪It maintains a patient's quality of life and requires only a short hospital stay.Leuthardt said, "When patients are told they have months to live, having the option of a low-risk procedure that gets them back home to their families in just
Newsweek files mainly under news. We currently carry 319 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Newsweek |
| Canonical URL | https://www.newsweek.com/new-treatments-show-promise-two-most-deadly-types-cancer-12335502 |
| Publication time | Fri, 21 Aug 2026 11:37:20 -0400 |
| Retrieval time | 2026-08-21T15:58:50.143Z |
| Last seen | 2026-08-21T15:58:50.143Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | None |
| Cluster logic | Not yet clustered, or no peer story found in the clustering window. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
By Rachael O'ConnorReporter0ShareNewsweek is a Trust Project memberSee more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.New treatments are being explored for two devastating cancers—glioblastoma and ovarian cancer—and they are showing promise.Glioblastoma is an aggressive form of brain cancer and the most common malignant brain tumor in adults, making up about half of all brain tumor cases, according to the Mayo Clinic.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Newsweek.